Induction and recall of immune memory by mucosal immunization with a non-toxic recombinant enterotoxin-based chimeric protein

被引:15
作者
Gockel, CM
Russell, MW
机构
[1] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14214 USA
[2] SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14214 USA
关键词
cholera toxin; memory cells; mucosal immunity; Streptococcus;
D O I
10.1111/j.1365-2567.2005.02246.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Previous reports have suggested that peroral delivery of antigens chemically coupled to non-toxic recombinant enterotoxin B subunits, such as the cholera toxin B subunit (CTB), induces tolerance to the antigen that may be abrogated by the toxic enzyme activity of intact enterotoxins, such as cholera toxin (CT). The aim of this study was to examine the immunogenicity of a genetically coupled protein composed of the saliva-binding region (SBR) of the Streptococcus mutans surface antigen AgI/II and the non-toxic A2 and B subunits of CT (SBR-CTA2/B) compared with that of recombinant SBR admixed with CT (SBR + CT) and SBR chemically coupled to recombinant CTB (SBR-CTB) following peroral delivery by intragastric (i.g.) immunization. The results showed that i.g. immunization with SBR-CTA2/B, like SBR + CT, induced antigen-specific serum immunoglobulin G (IgG) and salivary IgA antibodies, and sensitized splenic T cells. Comparison studies with SBR-CTB produced serum IgG but not salivary IgA titres and failed to sensitize splenic cells. Immunization with SBR-CTA2/B via the intranasal route also primed for the recall of antigen-specific memory antibody responses 6 months later. These findings show that SBR-CTA2/B is an immunogenic, not tolerogenic, chimeric protein that can induce and recall antigen-specific memory responses upon mucosal immunization.
引用
收藏
页码:477 / 486
页数:10
相关论文
共 55 条
[1]   Serum antibodies induced by intranasal immunization of mice with Plasmodium vivax Pvs25 co-administered with cholera toxin completely block parasite transmission to mosquitoes [J].
Arakawa, T ;
Tsuboi, T ;
Kishimoto, A ;
Sattabongkot, J ;
Suwanabun, N ;
Rungruang, T ;
Matsumoto, Y ;
Tsuji, N ;
Hisaeda, H ;
Stowers, A ;
Shimabukuro, I ;
Sato, Y ;
Torii, M .
VACCINE, 2003, 21 (23) :3143-3148
[2]   IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccinated by intranasal, intravenous and/or subcutaneous administration [J].
Asanuma, H ;
Aizawa, C ;
Kurata, T ;
Tamura, S .
VACCINE, 1998, 16 (13) :1257-1262
[3]   An enzymatically active A domain is required for cholera-like enterotoxins to induce a long-lived blockade on the induction of oral tolerance: New method for screening mucosal adjuvants [J].
Bagley, KC ;
Abdelwahab, SF ;
Tuskan, RG ;
Lewis, GK .
INFECTION AND IMMUNITY, 2003, 71 (12) :6850-6856
[4]  
BLEIWEIS AS, 1992, ADV EXP MED BIOL, V327, P229
[5]   The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes [J].
Bregenholt, S ;
Wang, M ;
Wolfe, T ;
Hughes, A ;
Bærentzen, L ;
Dyrberg, T ;
von Herrath, MG ;
Petersen, JS .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2003, 57 (05) :432-438
[6]  
BRUCE MG, 1986, IMMUNOLOGY, V57, P627
[7]   PROTEIN THIOLATION AND REVERSIBLE PROTEIN-PROTEIN CONJUGATION - N-SUCCINIMIDYL 3-(2-PYRIDYLDITHIO)PROPIONATE, A NEW HETEROBIFUNCTIONAL REAGENT [J].
CARLSSON, J ;
DREVIN, H ;
AXEN, R .
BIOCHEMICAL JOURNAL, 1978, 173 (03) :723-737
[8]   SYSTEMIC TOLERANCE AND SECRETORY IMMUNITY AFTER ORAL IMMUNIZATION [J].
CHALLACOMBE, SJ ;
TOMASI, TB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1980, 152 (06) :1459-1472
[9]   ORAL-ADMINISTRATION OF A STREPTOCOCCAL ANTIGEN COUPLED TO CHOLERA-TOXIN B-SUBUNIT EVOKES STRONG ANTIBODY-RESPONSES IN SALIVARY-GLANDS AND EXTRAMUCOSAL TISSUES [J].
CZERKINSKY, C ;
RUSSELL, MW ;
LYCKE, N ;
LINDBLAD, M ;
HOLMGREN, J .
INFECTION AND IMMUNITY, 1989, 57 (04) :1072-1077
[10]   Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasis [J].
De Bernardis, F ;
Boccanera, M ;
Adriani, D ;
Girolamo, A ;
Cassone, A .
INFECTION AND IMMUNITY, 2002, 70 (05) :2725-2729